Korea Investment Partners
Established in 1986, Korea Investment Partners is a prominent venture capital firm headquartered in Seoul. With over three decades of experience, the company invests globally in innovative startups across various sectors, including technology, healthcare, and manufacturing. Notable investments include Kakao, Naver, YG Entertainment, and Didi Chuxing. The firm manages multiple funds with total assets under management exceeding US$1.8 billion.
Top Sectors
https://crunchbase.com/organization/***
https://linkedin.com/company/***
https://signal.nfx.com/firms/***
Past deals in Dental
Hisense Bio
Series C in 2021
Hisense Bio offers treatment for intractable dental diseases. They provide research on original technology for tooth development and dentin regeneration. They developed physiological dentin regeneration technology and periodontal ligament regeneration technology based on basic dental research . They offer treatment of intractable dental diseases such as tooth decay, dental hypersensitivity, tooth decay, dental caries, and periodontal disease.
eBrace
Series B in 2020
eBrace is a company focused on the research, development, and production of digital 3D printing technology specifically tailored for orthodontics. The firm specializes in creating innovative solutions for dental applications, including bracketless invisible appliances, customized lingual invisible appliances, and dentures. By leveraging advanced 3D printing techniques, eBrace aims to deliver precise and detailed dental products that meet the needs of both practitioners and patients.
Hisense Bio
Series B in 2019
Hisense Bio offers treatment for intractable dental diseases. They provide research on original technology for tooth development and dentin regeneration. They developed physiological dentin regeneration technology and periodontal ligament regeneration technology based on basic dental research . They offer treatment of intractable dental diseases such as tooth decay, dental hypersensitivity, tooth decay, dental caries, and periodontal disease.
Hisense Bio
Series A in 2018
Hisense Bio offers treatment for intractable dental diseases. They provide research on original technology for tooth development and dentin regeneration. They developed physiological dentin regeneration technology and periodontal ligament regeneration technology based on basic dental research . They offer treatment of intractable dental diseases such as tooth decay, dental hypersensitivity, tooth decay, dental caries, and periodontal disease.
Gloud
Gloud offers dental digital and digital practice transformation services.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.